Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice
- 1 May 1991
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 9 (3) , 259-272
- https://doi.org/10.1007/bf01753729
Abstract
In order to study differences in antigen expression related to the different stages of the process of metastasis of human melanoma cell lines, we determined the expression pattern of a series of well-characterized genes in a set of human melanoma cell lines with different metastatic behavior in nude mice. This set included non-metastatic (IF6, 530), sporadically metastatic (M14, Mel 57), and frequently metastatic (BLM, MV3) cell lines after subcutaneous inoculation. To study the phenotype of these cell lines both the cultured cells and representative samples of local tumors at the inoculation site and their metastases in the lungs were immunostained with a panel of monoclonal antibodies directed against melanocytic differentiation or progression antigens. Although most cell lines (IF6, 530, M14 and Mel 57) showed HLA-DR expressionin vitro, these antigens were lacking in all xenografted lesions studied with exception of the 530 cell line. 530 Xenografts, however, showed a dramatic down-regulation of HLA-DR compared with the cell linein vitro. The same phenomenon was seen with respect to ICAM-1 expression. The expression of all other antigens studied in xenografts, both in subcutaneous tumors and in lung lesions, was in general comparable to that in the melanoma cell linesin vitro, with exception of the 530 cell line. In all melanoma cell lines except 530 the degree of intra- and interlesional heterogeneity regarding the expression of all antigens studied was limited. Remarkably, comparison of the immunophenotype of the frequently metastasizing (BLM, MV3) and the sporadically (M14, Mel 57) or non-metastasizing (IF6, 530) cell lines showed that the two frequently metastasizing cell lines had marked expression of the progression antigens VLA-2 and epidermal growth factor receptor, and lack of expression of the differentiation antigen NKI-beteb. These findings warrant further studies on the role of these antigens in the process of metastasis of human melanoma cells in nude mice.Keywords
This publication has 42 references indexed in Scilit:
- Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude miceInternational Journal of Cancer, 1991
- Expression of 38-kD Cell-Surface Glycoprotein in Transformed Keratinocyte Cell Lines, Basal Cell Carcinomas, and Epithelial GermsJournal of Investigative Dermatology, 1990
- Monoclonal Antibody PAL-M1 Recognizes the Transferrin Receptor and Is a Progression Marker in Melanocytic LesionsJournal of Investigative Dermatology, 1990
- Interferon gamma regulates HLA-D expression on solid tumors in vivoEuropean Journal of Cancer and Clinical Oncology, 1986
- Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid originHuman Immunology, 1986
- Monoclonal Antibodies Selected to Discriminate Between Malignant Melanomas and Nevocellular NeviJournal of Investigative Dermatology, 1985
- A tumor-associated antigen expressed in melanoma cells with lower malignant potentialInternational Journal of Cancer, 1985
- Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.The Journal of Experimental Medicine, 1984
- Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue originEuropean Journal of Immunology, 1981
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978